{"id":47652,"date":"2019-09-20T18:56:20","date_gmt":"2019-09-20T18:56:20","guid":{"rendered":"https:\/\/merryjane.com\/psychedelics-can-help-treat-a-variety-of-psychiatric-disorders-new-review-says\/"},"modified":"2019-09-20T18:56:20","modified_gmt":"2019-09-20T18:56:20","slug":"psychedelics-can-help-treat-a-variety-of-psychiatric-disorders-new-review-says","status":"publish","type":"post","link":"https:\/\/merryjane.com\/news\/psychedelics-can-help-treat-a-variety-of-psychiatric-disorders-new-review-says\/","title":{"rendered":"Psychedelics Can Help Treat a Variety of Psychiatric Disorders, New Review Says"},"content":{"rendered":"
A new scientific review<\/u><\/a> published in this month’s Journal of Psychiatric Practice <\/em>reported that psychedelics<\/a> have successfully been used to reduce symptoms linked to at least eight different psychiatric disorders. And since today is National Psilocybin Mushroom Day<\/a>, we figured there was no better time to break down this news for you.<\/p>\n Researchers from the University of Texas Health Science Center at San Antonio reviewed sixteen previously-published studies<\/u><\/a> exploring whether psychedelic drugs could help treat a variety of disorders. These original studies, published between 1946 and 2017, examined the effects of ibogaine, ketamine, LSD<\/a>, MDMA<\/a>, psilocybin<\/a>, ayahuasca<\/a>, and other drugs on patients suffering from conditions like depression, substance use disorders, and PTSD.<\/p>\n \u201cThe conditions treated ranged from depression to autism, with the largest volume of research dedicated to substance use disorders,\u201d the researchers wrote<\/u><\/a>. \u201cThe majority of studies that were reviewed demonstrated significant associations with improvement in the conditions investigated.\u201d <\/p>\n Out of the 16 studies reviewed, 15 found that hallucinogen-based therapy \u201cproduced clinically significant reduction in\u201d symptoms of psychiatric disorders.<\/p>\n Specifically, the review noted two studies that found that ayahuasca helped reduce the symptoms of treatment resistant depression, and another study which found that MDMA-assisted therapy helped patients deal with PTSD associated with sexual trauma. Several other studies found that ibogaine, ketamine, LSD, and dipropyltryptamine<\/u><\/a> (a synthetic hallucinogen known as DPT or \u201cThe Light\u201d) all showed evidence of helping patients struggling with substance use disorder remain sober.<\/p>\n